Literature DB >> 852502

Muscimol antagonizes the ergometrine-induced locomotor activity in nucleus accumbens: evidence for a GABA--dopaminergic interaction.

J Scheel-Krüger, A R Cools, W Honig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 852502     DOI: 10.1016/0014-2999(77)90300-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  7 in total

1.  Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.

Authors:  G Anlezark; B Meldrum
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

2.  Cataleptic and anticataleptic effects of muscimol and gabaculine injected into globus pallidus and substantia nigra, and interactions with haloperidol or benzodiazepines.

Authors:  Y Matsui; T Kamioka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-12       Impact factor: 3.000

3.  Dopamine-dependent hyperactivity in the rat following manipulation of GABA mechanisms in the region of the nucleus accumbens.

Authors:  C J Pycock; R W Horton
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

4.  Conditional Regulation of Blood Pressure in Response to Emotional Stimuli by the Central Nucleus of the Amygdala in Rats.

Authors:  Ko Yamanaka; Hidefumi Waki
Journal:  Front Physiol       Date:  2022-06-01       Impact factor: 4.755

5.  Effect of sodium valproate on motor function regulated by the activation of GABA receptors.

Authors:  A Kuruvilla; N J Uretsky
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 6.  Physiological and behavioral studies with muscimol.

Authors:  F V DeFeudis
Journal:  Neurochem Res       Date:  1980-10       Impact factor: 3.996

7.  Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum.

Authors:  J de Belleroche; I M Gardiner
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.